AdaptHealth price to free cash flow AHCO
Market value divided by free cash flow over the last twelve months, since 2020.
- Today, Oct 23, 2026
- 8.4×
- 6-year median
- 23.7×
- Against its 6-year history
- 33rd
- percentile: 0 is its lowest day, 100 its highest
- 6-year range
- 4.1× to 161×
- Peer median
- 12.6×
AdaptHealth's price to free cash flow is 8.4× as of Oct 23, 2026.
That is below its 6-year median of 23.7×, lower than on 67% of days in the last 6 years.
Over that time it ranged from 4.1× in Jun 2025 to 161× in Aug 2022.
The median for 10 hospital and care facility stocks of a similar size is 12.6×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 8.4× | 5.7× | 9.1× |
| 2025 | 6.5× | 4.1× | 6.6× |
| 2024 | 5.6× | 5.6× | 33.4× |
| 2023 | 32.5× | 28.9× | 87.1× |
| 2022 | 39.4× | 23.4× | 161× |
| 2021 | 47.2× | 15.5× | 48.7× |
| 2020 | 18.9× | 15.0× | 19.1× |
Against its peers
Companies in Medical - Care Facilities nearest AdaptHealth's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| AHCOAdaptHealth | 8.4× |
| OMDAOmada Health | 51.0× |
| SBCSBC Medical | 8.8× |
| USPHU S Physical Therapy | 20.6× |
| PNTGPennant | 42.2× |
| ARDTArdent Health | 5.7× |
| HCSGHealthcare Services | 11.7× |
| VMDViemed Healthcare | 12.8× |
| PGNYProgyny | 12.5× |
| ADUSAddus HomeCare | 14.7× |
| MDPediatrix Medical | 10.4× |
| Peer median | 12.6× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on AdaptHealth
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.